Most media planning still carries the DNA of consumer advertising: maximize reach, optimize frequency, trust the funnel. That logic collapses when your total addressable audience is a few thousand people. A hospital system marketing to interventional cardiologists, an industrial manufacturer selling to municipal utility directors, a graduate program recruiting internationally mobile applicants — these audiences aren't segments of a mass market. They're lists. And lists demand a different playbook.

The case for precision over reach

Start with the number that reframes everything: research across B2B categories consistently finds that only around 5% of buyers are actively in-market at any given moment. Broad awareness campaigns spend 95% of their impressions on people who cannot act. Person-level and account-based targeting inverts that spend — concentrating budget on identified, named individuals and organizations, sequenced by where they sit in their decision journey.

The results data on this approach has become hard to argue with. Roughly three-quarters of marketers report that account-based programs deliver higher ROI than any other marketing strategy they run, and one large 2025 survey of 771 marketers found organizations averaging an estimated 137% return on their ABM investment. Companies now allocate close to a third of their marketing budgets to account-based approaches, and a majority of B2B marketers report larger average deal sizes after adopting them. Precision doesn't just cost less per outcome — it changes the quality of the outcomes.

What hyper-targeting actually looks like in practice

The mechanics matter more than the label. In our work, four disciplines separate genuine person-level programs from broad campaigns wearing an ABM badge.

First, the audience is built, not bought. Named accounts and named roles — specific titles, seniority levels, specialties, or credentials — assembled from first-party data, intent signals, and platform-native targeting. Nearly all sophisticated B2B teams now use intent data to prioritize who sees what, and when.

Second, the message is sequenced. An audience that has never heard of you gets a different message than one that visited your site last week. Converted leads get suppressed entirely, so budget never chases people already in the funnel — an embarrassingly common leak in broad campaigns.

Third, frequency is deliberately low until it needs not to be. For a narrow audience, always-on presence at modest impression levels keeps you known without exhausting the list; concentrated bursts are reserved for the moments that matter — a product launch, a conference week, an application deadline.

Fourth, everything reports to one scoreboard: cost per qualified lead, attributed to the placement that produced it. Not impressions, not clicks — qualified people, traced to source.

The same math, across very different worlds

What makes this discipline interesting is how portable it is. Healthcare-professional marketing has run on it for years, because the audience — prescribers in a given specialty — is finite and identifiable. Industrial B2B is the same: the universe of municipal water-treatment decision-makers in a region might number a few hundred. And the pattern extends anywhere the audience is small, global, and high-consideration: executive education and graduate-program recruitment, for example, involves reaching a dispersed international pool of career-driven prospects through the specific channels and publications they already trust — the same sponsorship-and-precision play, aimed at a different list.

In each case the strategic question is identical: who exactly are the people who can say yes, where do they already spend attention, and what is the cheapest reliable path to a qualified conversation with each of them? When you can name your market, you should never be paying to reach anyone else.

‍